Compounding Event
Compounding Event
COMPOUNDING TEAM
FACILITATOR: Mr. Chigozirim Woke
Mr. Chigozirim Woke Ms. Esther Ekine
Ms. Naomi Chikezie
COMPOUNDING EVENT
The International Pharmaceutical Students’ Federation (IPSF) created the Compounding Event (CE) in order
to highlight the importance and necessity of compounding skills within the pharmacy profession, especially
as we move towards personalized medicine in healthcare.
This event was first introduced at the 59th IPSF World Congress in Utrecht, the Netherlands in 2013. The
Compounding Event has four main objectives:
i. It raises awareness about the importance of compounding and quality/security measures regarding the
production of compounded pharmaceutical products.
ii. It teaches students to recognize which patients need personalized medicines that are not available.
iii. It provides students with an opportunity to develop knowledge in designing and preparing
compounded pharmaceutical formulations.
iv. It provides pharmacy students the opportunity to practice compounding skills in an environment that is
conducive to learning.
What is Compounding?
According to the United States Pharmacopeia (USP), compounding in pharmacy is “the
preparation, mixing, assembling, altering, packaging, and labelling of a drug, drug-delivery
device, or device in accordance with a licensed practitioner’s prescription, medication order, or
initiative based on the practitioner/patient/pharmacist/compounder relationship in the course
of professional practice.”
In simpler terms, compounding in pharmacy refers to adding, mixing, altering, or removing
elements of a prescription to customize it for a patient based on a doctor’s orders.
Types of Compounding
Sterile and Non-sterile Compounding
1. Sterile Compounding: This refers to the practice of preparing pharmaceutical products in a
sterile environment to prevent microbial contamination. It is the preparation of medications
that are administered in a way that has a high risk for infection, such as intravenous (IV)
infusion, injections, or ophthalmic (eye) preparations.
2. Non-sterile Compounding: It involves the creation of medications that are administered in
ways that do not have a high risk of infection, such as orally or topically. These types of
medications include ointments, creams, capsules, tablets, powders, troches (pill that dissolves
under the tongue) etc.
Non-sterile compounding is more common than sterile compounding. Unlike sterile compounding,
non-sterile compounding does not require a designated sterile room to compound medications.
However, the process still meet strict regulations for purity, mixing, packaging, and labelling.
Why Compounding?
It is fundamental to pharmacy practice.
Extemporaneously compounded medicine are useful when a required dose or dosage form is
unavailable commercially.
Compounded medications are essential for patients who are allergic to a component in a
commercially approved version of the drug.
Compounding personnel are responsible for compounding and dispensing of extemporaneous
products and preparation of CORRECT ingredient, identity, purity, strength (including stability
and compatibility), and sterility and for dispensing them in appropriate containers that are
labelled accurately and appropriately for patients.
PRELIMINARY STAGE:
MCQ-based tests on general compounding knowledge.
20 questions to be answered in 10 minutes.
Questions will be released on 28th September.
Finalist will be announced on the 30th September.
Grading is based on the form, and if there is a tie, the time of submission will be used as criteria
for breaking the tie.
FINAL STAGE: 6th October
Theme is Paediatric formulations
Stage is divided into Junior and Senior categories.
Case will be released 24hrs to event time.
Teams will discuss the case within themselves.
On the day of the event, teams will be issued a worksheet to answer questions based on the
case with an allotted time.
Rubric for Grading for Final Stage
Approach in answering the questions
Detailed steps and calculations where necessary
Time of submission
Physical appearance
NOTE: THE RESULT FROM THE JUDGES IS FINAL, HENCE IT CANNOT BE CONTESTED.
CASE SAMPLE
CJ, a 7 year old boy was brought to your pharmacy by his father. His father explains that his son
has been diagnosed with an ear infection and he gives you a prescription from a doctor for oral
amoxicillin suspension. You do not have the suspension in your pharmacy but you have
amoxicillin powder in a strength of 250mg/5mL as well as a suitable suspending vehicle. You are
to compound the amoxicillin suspension there in your pharmacy.
Rx
Name of patient: CJ
Age: 7 years
Weight: 22kg
Oral Amoxicillin Suspension 125mg/5mL
20mL 8 hourly for 10 days
You have the following ingredients:
1. Amoxicillin 250/5mL
2. Suspending agent: 100mL
3. BD oral syringe 5mL
4. Suspension bottle: 50mL
Item Name
Compounding Steps
Compounded by:
Compounded date: